As SARS-Cov-2 will likely be around for quite some time, such a development will be important. If ENTA does develop one then its slow and deliberate approach from scratch will be validated as opposed to the throwing what you have at Covid-19 and hope it works.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.